CD4 and neoplasm: found that TRP-1 CD4+ T cells isolated from ACT mice receiving CD4+ T could reprogram the myeloid cells network in the TME, which means IFN-γ produced by CD4+ T and myeloid cell-derived iNOS produced a tumor-killing phenotype through a synergistic effect (196).